On the bases of all published cases, it seems that patients with KCNJ2 mutations can be identified among CPVT cohorts by accurate phenotypical description (ECG features, sex, age and severity of symptoms, associated signs). Here, KCNJ2 is linked to catecholaminergic polymorphic ventricular tachycardia.